Home    Back

Target Gene/Pathway💬 Info on mouse-over

e.g. Sirolimus, Adalimumab, MAP2K

ABCDEFGH I JKLMNOPQRSTUVWXYZother

152 / 286 pathways

No. KEGG PATHWAY
On map, Yellow: Drug target, Red: All disease-related		 KEGG GENES KEGG DRUG DrugBank Disease ID
1 Acute myeloid leukemia 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
2 Adherens junction 💬
 [1] FGFR1 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
3 Adipocytokine signaling pathway 💬
 [1] JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
4 Adipocytokine signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
5 Adipocytokine signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
6 Adipocytokine signaling pathway 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
7 Adrenergic signaling in cardiomyocytes 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
8 Adrenergic signaling in cardiomyocytes 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
9 Adrenergic signaling in cardiomyocytes 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
10 Adrenergic signaling in cardiomyocytes 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
11 African trypanosomiasis 💬
 [4] IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
12 African trypanosomiasis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
13 AGE-RAGE signaling pathway in diabetic complications 💬
 [5] CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
14 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
15 AGE-RAGE signaling pathway in diabetic complications 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
16 Allograft rejection 💬
 [2] IL10, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
17 Allograft rejection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
18 Alzheimer disease 💬
 [4] IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
19 Alzheimer disease 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
20 Alzheimer disease 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
21 Alzheimer disease 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
22 Alzheimer disease 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
23 Alzheimer disease 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
24 Alzheimer disease 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
25 Amoebiasis 💬
 [4] IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
26 Amoebiasis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
27 Amphetamine addiction 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
28 Amphetamine addiction 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
29 Amphetamine addiction 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
30 AMPK signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
31 Amyotrophic lateral sclerosis 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
32 Amyotrophic lateral sclerosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
33 Amyotrophic lateral sclerosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
34 Amyotrophic lateral sclerosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
35 Amyotrophic lateral sclerosis 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
36 Amyotrophic lateral sclerosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
37 Amyotrophic lateral sclerosis 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
38 Antifolate resistance 💬
 [3] IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
39 Antifolate resistance 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
40 Antigen processing and presentation 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
41 Antigen processing and presentation 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
42 Apelin signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
43 Apoptosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
44 Apoptosis 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
45 Asthma 💬
 [2] IL10, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
46 Asthma 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
47 Autoimmune thyroid disease 💬
 [1] IL10 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
48 Autophagy - animal 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
49 Autophagy - other 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
50 Axon guidance 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
51 Axon guidance 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
52 Axon guidance 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
53 B cell receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
54 B cell receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
55 B cell receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
56 Bladder cancer 💬
 [1] FGFR3 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
57 Breast cancer 💬
 [2] FGFR1, FLT4 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
58 Breast cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
59 C-type lectin receptor signaling pathway 💬
 [4] IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
60 C-type lectin receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
61 C-type lectin receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
62 C-type lectin receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
63 C-type lectin receptor signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
64 Calcium signaling pathway 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
65 Calcium signaling pathway 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
66 Calcium signaling pathway 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
67 Calcium signaling pathway 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
68 Calcium signaling pathway 💬
 [1] CYSLTR1 💬 D00529 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
69 Calcium signaling pathway 💬
 [1] CYSLTR1 💬 D08229 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
70 Calcium signaling pathway 💬
 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
71 Calcium signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
72 Calcium signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
73 Calcium signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
74 cAMP signaling pathway 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
75 cAMP signaling pathway 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
76 cAMP signaling pathway 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
77 cAMP signaling pathway 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
78 Cellular senescence 💬
 [2] IL1A, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
79 Cellular senescence 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
80 Cellular senescence 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
81 Cellular senescence 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
82 Cellular senescence 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
83 Central carbon metabolism in cancer 💬
 [5] FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
84 Central carbon metabolism in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
85 cGMP-PKG signaling pathway 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
86 cGMP-PKG signaling pathway 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
87 cGMP-PKG signaling pathway 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
88 cGMP-PKG signaling pathway 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
89 cGMP-PKG signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
90 cGMP-PKG signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
91 cGMP-PKG signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
92 Chagas disease 💬
 [5] CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
93 Chagas disease 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
94 Chagas disease 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
95 Chemokine signaling pathway 💬
 [1] CCL2 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
96 Chemokine signaling pathway 💬
 [1] JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
97 Choline metabolism in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
98 Choline metabolism in cancer 💬
 [2] PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
99 Cholinergic synapse 💬
 [1] JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
100 Colorectal cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
101 Coronavirus disease - COVID-19 💬
 [4] CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
102 Coronavirus disease - COVID-19 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
103 Coronavirus disease - COVID-19 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
104 Coronavirus disease - COVID-19 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
105 Cytokine-cytokine receptor interaction 💬
 [6] CCL2, IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
106 Cytokine-cytokine receptor interaction 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
107 Cytokine-cytokine receptor interaction 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
108 Cytokine-cytokine receptor interaction 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
109 Cytosolic DNA-sensing pathway 💬
 [2] IL1B, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
110 Diabetic cardiomyopathy 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
111 Dilated cardiomyopathy 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
112 Dilated cardiomyopathy 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
113 Dopaminergic synapse 💬
 [3] PPP3CA, PPP3CB, PPP3CC 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
114 Dopaminergic synapse 💬
 [3] PPP3CA, PPP3CB, PPP3CC 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
115 Dopaminergic synapse 💬
 [3] PPP3CA, PPP3CB, PPP3CC 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
116 Drug metabolism - other enzymes 💬
 [2] IMPDH1, IMPDH2 💬 D05096 💬 Mycophenolic acid [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
117 EGFR tyrosine kinase inhibitor resistance 💬
 [5] FGFR2, FGFR3, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
118 EGFR tyrosine kinase inhibitor resistance 💬
 [1] IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
119 EGFR tyrosine kinase inhibitor resistance 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
120 EGFR tyrosine kinase inhibitor resistance 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
121 EGFR tyrosine kinase inhibitor resistance 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
122 Endocrine and other factor-regulated calcium reabsorption 💬
 [1] VDR 💬 D00188 💬 Cholecalciferol [23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
123 Endocrine resistance 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
124 Endocytosis 💬
 [3] FGFR2, FGFR3, PDGFRA 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
125 Endocytosis 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
126 Epstein-Barr virus infection 💬
 [2] IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
127 Epstein-Barr virus infection 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
128 Epstein-Barr virus infection 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
129 Epstein-Barr virus infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
130 ErbB signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
131 Fc epsilon RI signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
132 Fc epsilon RI signaling pathway 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
133 Fluid shear stress and atherosclerosis 💬
 [4] CCL2, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
134 Fluid shear stress and atherosclerosis 💬
 [1] KDR 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
135 Fluid shear stress and atherosclerosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
136 Focal adhesion 💬
 [5] FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
137 FoxO signaling pathway 💬
 [2] IL10, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
138 Gap junction 💬
 [2] PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
139 Gastric cancer 💬
 [1] FGFR2 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
140 Gastric cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
141 Glioma 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
142 Glioma 💬
 [2] PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
143 Glucagon signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
144 Glucagon signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
145 Glucagon signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
146 Glutamatergic synapse 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
147 Glutamatergic synapse 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
148 Glutamatergic synapse 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
149 Graft-versus-host disease 💬
 [4] IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
150 Graft-versus-host disease 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
151 Growth hormone synthesis, secretion and action 💬
 [1] JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
152 Growth hormone synthesis, secretion and action 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
153 Hematopoietic cell lineage 💬
 [4] IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
154 Hematopoietic cell lineage 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
155 Hematopoietic cell lineage 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
156 Hepatitis B 💬
 [2] IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
157 Hepatitis B 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
158 Hepatitis B 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
159 Hepatitis B 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
160 Hepatitis C 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
161 Hepatitis C 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
162 Hepatitis C 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
163 Hepatitis C 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
164 Hepatocellular carcinoma 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
165 Herpes simplex virus 1 infection 💬
 [4] CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
166 Herpes simplex virus 1 infection 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
167 Herpes simplex virus 1 infection 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
168 Herpes simplex virus 1 infection 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
169 Herpes simplex virus 1 infection 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
170 Herpes simplex virus 1 infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
171 HIF-1 signaling pathway 💬
 [1] FLT1 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
172 HIF-1 signaling pathway 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
173 HIF-1 signaling pathway 💬
 [1] IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
174 HIF-1 signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
175 Human cytomegalovirus infection 💬
 [4] CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
176 Human cytomegalovirus infection 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
177 Human cytomegalovirus infection 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
178 Human cytomegalovirus infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
179 Human cytomegalovirus infection 💬
 [1] PDGFRA 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
180 Human cytomegalovirus infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
181 Human cytomegalovirus infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
182 Human cytomegalovirus infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
183 Human cytomegalovirus infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
184 Human immunodeficiency virus 1 infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
185 Human immunodeficiency virus 1 infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
186 Human immunodeficiency virus 1 infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
187 Human immunodeficiency virus 1 infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
188 Human immunodeficiency virus 1 infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
189 Human immunodeficiency virus 1 infection 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
190 Human papillomavirus infection 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
191 Human papillomavirus infection 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
192 Human papillomavirus infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
193 Human papillomavirus infection 💬
 [1] PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
194 Human papillomavirus infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
195 Human papillomavirus infection 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
196 Human T-cell leukemia virus 1 infection 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
197 Human T-cell leukemia virus 1 infection 💬
 [2] IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
198 Human T-cell leukemia virus 1 infection 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
199 Human T-cell leukemia virus 1 infection 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
200 Human T-cell leukemia virus 1 infection 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
201 Human T-cell leukemia virus 1 infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
202 Human T-cell leukemia virus 1 infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
203 Human T-cell leukemia virus 1 infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
204 Huntington disease 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
205 Huntington disease 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
206 Hypertrophic cardiomyopathy 💬
 [2] IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
207 Hypertrophic cardiomyopathy 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
208 IL-17 signaling pathway 💬
 [4] CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
209 IL-17 signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
210 Inflammatory bowel disease 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
211 Inflammatory bowel disease 💬
 [5] IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
212 Inflammatory bowel disease 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
213 Inflammatory mediator regulation of TRP channels 💬
 [1] IL1B 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
214 Influenza A 💬
 [5] CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
215 Influenza A 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
216 Influenza A 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
217 Influenza A 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
218 Influenza A 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
219 Insulin resistance 💬
 [2] IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
220 Insulin resistance 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
221 Insulin resistance 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
222 Insulin signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
223 Intestinal immune network for IgA production 💬
 [2] IL10, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
224 JAK-STAT signaling pathway 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
225 JAK-STAT signaling pathway 💬
 [2] IL10, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
226 JAK-STAT signaling pathway 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
227 JAK-STAT signaling pathway 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
228 JAK-STAT signaling pathway 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
229 JAK-STAT signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
230 JAK-STAT signaling pathway 💬
 [2] PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
231 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] IFNGR1 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
232 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
233 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
234 Kaposi sarcoma-associated herpesvirus infection 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
235 Kaposi sarcoma-associated herpesvirus infection 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
236 Kaposi sarcoma-associated herpesvirus infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
237 Kaposi sarcoma-associated herpesvirus infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
238 Kaposi sarcoma-associated herpesvirus infection 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
239 Legionellosis 💬
 [3] IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
240 Legionellosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
241 Leishmaniasis 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
242 Leishmaniasis 💬
 [4] IL10, IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
243 Leishmaniasis 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
244 Leishmaniasis 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
245 Leishmaniasis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
246 Long-term potentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
247 Long-term potentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
248 Long-term potentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
249 Longevity regulating pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
250 Longevity regulating pathway - multiple species 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
251 Malaria 💬
 [5] CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
252 Malaria 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
253 MAPK signaling pathway 💬
 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
254 MAPK signaling pathway 💬
 [3] IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
255 MAPK signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
256 MAPK signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
257 MAPK signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
258 MAPK signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
259 Measles 💬
 [3] IL1A, IL1B, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
260 Measles 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
261 Measles 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
262 Measles 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
263 Melanoma 💬
 [3] FGFR1, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
264 Metabolic pathways 💬
 [2] IMPDH1, IMPDH2 💬 D05096 💬 Mycophenolic acid [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
265 MicroRNAs in cancer 💬
 [3] FGFR3, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
266 MicroRNAs in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
267 Mineral absorption 💬
 [1] VDR 💬 D00188 💬 Cholecalciferol [23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
268 mTOR signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
269 mTOR signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
270 mTOR signaling pathway 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
271 Natural killer cell mediated cytotoxicity 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
272 Natural killer cell mediated cytotoxicity 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
273 Natural killer cell mediated cytotoxicity 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
274 Natural killer cell mediated cytotoxicity 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
275 Natural killer cell mediated cytotoxicity 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
276 Natural killer cell mediated cytotoxicity 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
277 Necroptosis 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
278 Necroptosis 💬
 [3] IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
279 Necroptosis 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
280 Necroptosis 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
281 Necroptosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
282 Neuroactive ligand-receptor interaction 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
283 Neuroactive ligand-receptor interaction 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
284 Neuroactive ligand-receptor interaction 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
285 Neuroactive ligand-receptor interaction 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
286 Neuroactive ligand-receptor interaction 💬
 [1] CYSLTR1 💬 D00529 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
287 Neuroactive ligand-receptor interaction 💬
 [1] CYSLTR1 💬 D08229 💬 Montelukast [5] 13, 46, 85, 98, 228 💬
288 Neuroactive ligand-receptor interaction 💬
 [1] NR3C1 💬 D00246 💬 Budesonide [9] 66, 93, 94, 95, 96, 97, 98, 228, 299 💬
289 Neuroactive ligand-receptor interaction 💬
 [1] NR3C1 💬 D07981 💬 Fluticasone [3] 98, 228, 299 💬
290 Neuroactive ligand-receptor interaction 💬
 [1] NR3C1 💬 D01708 💬 Fluticasone propionate [2] 98, 228 💬
291 Neuroactive ligand-receptor interaction 💬
 [1] NR3C1 💬 D00473 💬 Prednisone [47]  2 ,  6 , 11, 13, 14, 19, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 93, 95, 96, 97, 113, 127, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 💬
292 Neutrophil extracellular trap formation 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
293 NF-kappa B signaling pathway 💬
 [2] IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
294 NF-kappa B signaling pathway 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
295 NOD-like receptor signaling pathway 💬
 [4] CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
296 NOD-like receptor signaling pathway 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
297 NOD-like receptor signaling pathway 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
298 NOD-like receptor signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
299 Non-alcoholic fatty liver disease 💬
 [4] IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
300 Non-alcoholic fatty liver disease 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
301 Oocyte meiosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
302 Oocyte meiosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
303 Oocyte meiosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
304 Osteoclast differentiation 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
305 Osteoclast differentiation 💬
 [3] IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
306 Osteoclast differentiation 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
307 Osteoclast differentiation 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
308 Osteoclast differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
309 Osteoclast differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
310 Osteoclast differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
311 Osteoclast differentiation 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
312 Oxytocin signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
313 Oxytocin signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
314 Oxytocin signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
315 Pancreatic cancer 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
316 Pancreatic cancer 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
317 Pancreatic cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
318 Parathyroid hormone synthesis, secretion and action 💬
 [1] FGFR1 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
319 Parathyroid hormone synthesis, secretion and action 💬
 [1] VDR 💬 D00188 💬 Cholecalciferol [23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
320 Parkinson disease 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
321 Pathogenic Escherichia coli infection 💬
 [3] IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
322 Pathogenic Escherichia coli infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
323 Pathways in cancer 💬
 [6] FGFR1, FGFR2, FGFR3, FLT4, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
324 Pathways in cancer 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
325 Pathways in cancer 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
326 Pathways in cancer 💬
 [1] IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
327 Pathways in cancer 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
328 Pathways in cancer 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
329 Pathways in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
330 Pathways of neurodegeneration - multiple diseases 💬
 [4] IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
331 Pathways of neurodegeneration - multiple diseases 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
332 Pathways of neurodegeneration - multiple diseases 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
333 Pathways of neurodegeneration - multiple diseases 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
334 Pathways of neurodegeneration - multiple diseases 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
335 Pathways of neurodegeneration - multiple diseases 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
336 Pathways of neurodegeneration - multiple diseases 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
337 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
338 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
339 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
340 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
341 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
342 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
343 PD-L1 expression and PD-1 checkpoint pathway in cancer 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
344 Pertussis 💬
 [5] IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
345 Pertussis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
346 Phospholipase D signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
347 Phospholipase D signaling pathway 💬
 [2] PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
348 PI3K-Akt signaling pathway 💬
 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
349 PI3K-Akt signaling pathway 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
350 PI3K-Akt signaling pathway 💬
 [1] IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
351 PI3K-Akt signaling pathway 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
352 PI3K-Akt signaling pathway 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
353 PI3K-Akt signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
354 Prion disease 💬
 [4] IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
355 Prion disease 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
356 Prion disease 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
357 Prion disease 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
358 Prion disease 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
359 Prion disease 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
360 Prolactin signaling pathway 💬
 [1] JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
361 Prostate cancer 💬
 [4] FGFR1, FGFR2, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
362 Prostate cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
363 Proteasome 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
364 Proteoglycans in cancer 💬
 [2] FGFR1, KDR 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
365 Proteoglycans in cancer 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
366 Proteoglycans in cancer 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
367 Proteoglycans in cancer 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
368 Purine metabolism 💬
 [2] IMPDH1, IMPDH2 💬 D05096 💬 Mycophenolic acid [34]  2 , 11, 13, 19, 20, 28, 35, 36, 42, 43, 45, 49, 51, 53, 60, 62, 65, 66, 84, 85, 93, 95, 96, 162, 164, 222, 224, 226, 228, 234, 283, 284, 285, 300 💬
369 Rap1 signaling pathway 💬
 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
370 Ras signaling pathway 💬
 [8] FGFR1, FGFR2, FGFR3, FLT1, FLT4, KDR, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
371 Regulation of actin cytoskeleton 💬
 [5] FGFR1, FGFR2, FGFR3, PDGFRA, PDGFRB 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
372 Regulation of lipolysis in adipocytes 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
373 Regulation of lipolysis in adipocytes 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
374 Regulation of lipolysis in adipocytes 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
375 Regulation of lipolysis in adipocytes 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
376 Renin secretion 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
377 Renin secretion 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
378 Renin secretion 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
379 Renin secretion 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
380 Renin secretion 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
381 Renin secretion 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
382 Renin secretion 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
383 Rheumatoid arthritis 💬
 [5] CCL2, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
384 Rheumatoid arthritis 💬
 [1] FLT1 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
385 Rheumatoid arthritis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
386 RIG-I-like receptor signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
387 RIG-I-like receptor signaling pathway 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
388 Salivary secretion 💬
 [1] ADRB2 💬 D01373 💬 Formoterol [3] 85, 228, 299 💬
389 Salivary secretion 💬
 [1] ADRB2 💬 D05277 💬 Formoterol [3] 85, 228, 299 💬
390 Salivary secretion 💬
 [1] ADRB2 💬 D07990 💬 Formoterol [3] 85, 228, 299 💬
391 Salivary secretion 💬
 [1] ADRB2 💬 D02147 💬 Salbutamol [14]  3 , 11, 12, 13, 49, 85, 86, 89, 111, 113, 228, 231, 256, 299 💬
392 Salmonella infection 💬
 [3] IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
393 Salmonella infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
394 Shigellosis 💬
 [2] IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
395 Shigellosis 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
396 Shigellosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
397 Signaling pathways regulating pluripotency of stem cells 💬
 [3] FGFR1, FGFR2, FGFR3 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
398 Signaling pathways regulating pluripotency of stem cells 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
399 Signaling pathways regulating pluripotency of stem cells 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
400 Sphingolipid signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
401 Sphingolipid signaling pathway 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
402 Spinocerebellar ataxia 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
403 Spinocerebellar ataxia 💬
 [1] PSMB5 💬 D03150 💬 Bortezomib [15] 11, 13, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 283, 288, 331 💬
404 Staphylococcus aureus infection 💬
 [1] IL10 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
405 Systemic lupus erythematosus 💬
 [2] IL10, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
406 Systemic lupus erythematosus 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
407 T cell receptor signaling pathway 💬
 [2] IL10, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
408 T cell receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
409 T cell receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
410 T cell receptor signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
411 T cell receptor signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
412 TGF-beta signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
413 TGF-beta signaling pathway 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
414 Th1 and Th2 cell differentiation 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
415 Th1 and Th2 cell differentiation 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
416 Th1 and Th2 cell differentiation 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
417 Th1 and Th2 cell differentiation 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
418 Th1 and Th2 cell differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
419 Th1 and Th2 cell differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
420 Th1 and Th2 cell differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
421 Th17 cell differentiation 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
422 Th17 cell differentiation 💬
 [2] IL1B, IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
423 Th17 cell differentiation 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
424 Th17 cell differentiation 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
425 Th17 cell differentiation 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
426 Th17 cell differentiation 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
427 Th17 cell differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
428 Th17 cell differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
429 Th17 cell differentiation 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
430 Thermogenesis 💬
 [1] FGFR1 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
431 Thermogenesis 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
432 Thyroid hormone signaling pathway 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
433 TNF signaling pathway 💬
 [4] CCL2, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
434 TNF signaling pathway 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
435 Toll-like receptor signaling pathway 💬
 [3] IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
436 Toll-like receptor signaling pathway 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
437 Toxoplasmosis 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
438 Toxoplasmosis 💬
 [2] IL10, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
439 Toxoplasmosis 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
440 Toxoplasmosis 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
441 Toxoplasmosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
442 Transcriptional misregulation in cancer 💬
 [1] FLT1 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
443 Transcriptional misregulation in cancer 💬
 [1] IL6 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
444 Tuberculosis 💬
 [2] IFNGR1, IFNGR2 💬 D00747 💬 Interferon gamma-1b [7] 18, 65, 85, 228, 299, 301, 326 💬
445 Tuberculosis 💬
 [5] IL10, IL1A, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
446 Tuberculosis 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
447 Tuberculosis 💬
 [2] JAK1, JAK2 💬 D09959 💬 Ruxolitinib [1] 228 💬
448 Tuberculosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
449 Tuberculosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
450 Tuberculosis 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
451 Tuberculosis 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
452 Tuberculosis 💬
 [1] VDR 💬 D00188 💬 Cholecalciferol [23]  6 , 13, 19, 20, 28, 34, 46, 49, 51, 53, 56, 60, 65, 84, 85, 96, 97, 162, 202, 228, 271, 298, 299 💬
453 Type I diabetes mellitus 💬
 [3] IL1A, IL1B, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
454 Type I diabetes mellitus 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
455 Type II diabetes mellitus 💬
 [1] MTOR 💬 D02714 💬 Everolimus [9] 34, 67, 89, 96, 137, 157, 158, 228, 277 💬
456 Type II diabetes mellitus 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
457 Type II diabetes mellitus 💬
 [1] TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
458 VEGF signaling pathway 💬
 [1] KDR 💬 D10481 💬 Nintedanib [5] 51, 85, 89, 227, 228 💬
459 VEGF signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
460 VEGF signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
461 VEGF signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
462 Viral carcinogenesis 💬
 [1] JAK1 💬 D10944 💬 Itacitinib [5] 46, 51, 60, 97, 228 💬
463 Viral carcinogenesis 💬
 [1] JAK1 💬 D09959 💬 Ruxolitinib [1] 228 💬
464 Viral protein interaction with cytokine and cytokine receptor 💬
 [4] CCL2, IL10, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
465 Viral protein interaction with cytokine and cytokine receptor 💬
 [1] IL2RA 💬 D03058 💬 Basiliximab [7]  2 , 50, 65, 66, 97, 222, 228 💬
466 Viral protein interaction with cytokine and cytokine receptor 💬
 [2] LTA, TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬
467 Wnt signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00184 💬 Cyclosporine [43] 11, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 93, 95, 97, 113, 162, 164, 222, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 💬
468 Wnt signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D00107 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
469 Wnt signaling pathway 💬
 [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 💬 D08556 💬 Tacrolimus [32]  2 ,  6 , 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 227, 228, 283, 284, 285, 299 💬
470 Yersinia infection 💬
 [5] CCL2, IL10, IL1B, IL6, TNF 💬 D01583 💬 Pirfenidone [10] 34, 46, 50, 51, 58, 84, 85, 164, 222, 228 💬
471 Yersinia infection 💬
 [1] TNF 💬 D00742 💬 Etanercept [15] 15, 28, 35, 38, 39, 46, 50, 53, 56, 60, 85, 228, 271, 285, 298 💬

Back to top